Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 14

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Apr 14, 2016; 22(14): 3829-3836
Published online Apr 14, 2016. doi: 10.3748/wjg.v22.i14.3829

Table 1 Clinical characteristics of hepatocellular carcinoma patients

HBV: Hepatitis B virus; AFP: α-fetoprotein; TNM: Tumor-node-metastasis.

Citation: Pan LH, Yao M, Cai Y, Gu JJ, Yang XL, Wang L, Yao DF. Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma. World J Gastroenterol 2016; 22(14): 3829-3836
URL: https://www.wjgnet.com/1007-9327/full/v22/i14/3829.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i14.3829

Pan LH, Yao M, Cai Y, Gu JJ, Yang XL, Wang L, Yao DF. Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma. World J Gastroenterol 2016; 22(14): 3829-3836 [PMID: 27076768 DOI: 10.3748/wjg.v22.i14.3829]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.